The world's first dual-vector
13-valent pneumonia vaccine
can effectively prevent
Streptococcus pneumonia disease
You can now make an appointment in Baoshan to take a look~
The World Health Organization (WHO) lists pneumococcal diseases as a disease that requires "extremely high priority" to prevent using vaccines. Vaccination with pneumococcal vaccine is an effective means to prevent pneumococcal infection.
dual-vector 13-valent pneumonia vaccine features
① Technical breakthrough innovation: the use of dual-vector proteins can effectively improve immunogenicity.
② greatly relaxes the age limit for vaccination: It has good results for infants and young children aged 6 weeks to 5 years old (before the 6th birthday).
③The price is more affordable: its price is only 463.5 yuan per dose, which is more than 30% cheaper than imported vaccines. The supply is sufficient, bringing more convenience and benefits to Baoshan children.
Hazards of Streptococcus pneumoniae disease
1. Characteristics of Streptococcus pneumoniae
Stepococcus pneumoniae is the main pathogen of community-acquired pneumonia and is mainly transmitted through respiratory droplets. As a conditional pathogenic bacteria, it can be colonized in the nasopharynx of healthy people, and the bacterial rate in children is higher.
2. Susceptible objects of Streptococcus pneumoniae
htmlChildren under 5 years old, especially infants and young children under 2 years old, are particularly susceptible to this bacteria because their autoimmune function has not yet been developed and improved. htmlThe 10 countries with the highest number of pneumococcal disease infection in children under 05 are all in Africa and Asia, with China ranking second, accounting for 12% of the global total number of cases.3. Are the consequences serious infectious streptococcal pneumoniae?
Streptococcus pneumoniae can cause invasive diseases such as pneumonia, otitis media, meningitis, and , leading to severe sequelae such as deafness, mental retardation, paralysis, and even death in infants and young children.
4. How to treat Streptococcus pneumoniae after infection?
is usually treated with antibiotics. However, with the widespread use of antibiotics, the problem of drug resistance of Streptococcus pneumoniae has become increasingly difficult to treat this disease.
Epidemiological research in my country shows that pediatric pneumococcal drug resistance is becoming increasingly severe. At the same time, the incidence of cross-resistance and multidrug resistance to commonly used antibacterial drugs in my country is high.
vaccination with pneumococcal vaccine is an effective means to fight drug resistance. At the same time, vaccination with pneumococcal vaccine is the most economical and effective means to prevent pneumococcal infection.
13-valent pneumonia vaccination
dual-vector 13-valent pneumonia polysaccharide binding vaccine has been put into use in Shanghai. From now on, it can provide vaccination services for infants and children aged 6 weeks to 5 years old (before the 6th birthday) in the jurisdiction. Parents can choose to vaccinate according to the principle of voluntary and self-payment.
1, vaccination procedure
At present, Baoshan District provides 13-valent pneumonia vaccines from three different manufacturers for parents to choose from. The specific differences are as follows:
02 The difference between the three 13-valent pneumonia vaccines
Vaccination clinic information
Baoshan District Community Health Service Center
Regular outpatient opening information
(
Outpatient information is subject to the actual opening situation, please make an appointment through the Health Cloud.
Edited by: Xiao Lu
Information: Baoshan Disease Control
* Please indicate it from Shanghai Baoshan official WeChat
